Skip to main content

Find Clinical Trials

Home
Conditions
Hematologic Malignancy

Clinical trial condition

Hematologic Malignancy

Explore clinical trials studying Hematologic Malignancy. Study availability and eligibility vary by location and protocol.

166 public trials 63 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Malignancy trial results

Active, Not Recruiting

Mechanism and Immune Function Analysis of SARS-CoV-2 Infection in Hematologic Tumors

NCT05683353

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +18 more
Locations: Peking University First Hospital Beijing, Beijing Municipality, China

View Trial Details

Active, Not Recruiting

Low-Flow vs. High-Flow Nasal Cannula for Hypoxemic Immunocompromised Patients During Diagnostic Bronchoscopy

NCT03168815

Conditions: Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +10 more
Locations: Mount Sinai Hospital Toronto, Ontario, Canada

View Trial Details

Active, Not Recruiting

Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study

NCT05396157

Conditions: Bleeding Hemorrhage, Blood Platelet Disorders, Cardiovascular Diseases, +17 more
Locations: Federico Carini Toronto, Ontario, Canada

View Trial Details

Active, Not Recruiting

Critical Care Outcomes of Hematologic Oncology Patients

NCT03449953

Conditions: Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +4 more
Locations: Foothills Hospital Calgary, Alberta, Canada

University of Alberta Edmonton, Alberta, Canada

Vancouver General Hospital Vancouver, British Columbia, Canada

University of Manitoba Winnipeg, Manitoba, Canada

View all 13 locations

View Trial Details

Active, Not Recruiting

Patient Fitness and Body Composition During Hematopoietic Stem Cell Transplantation

NCT02990130

Conditions: Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +3 more
Locations: VA Puget Sound Health Care System Seattle, Washington, United States

View Trial Details

Active, Not Recruiting

Safety/PK Study of Gene Modified Donor T Cell Infusion in Children With Recurrent Hem Malignancies After Allo Transplant

NCT03459170

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hematologic Malignancy, +16 more
Locations: San Matteo Hospital Pavia, Italy

IRCCS Ospedale Pediatrico Bambino Gesù Rome, Italy

Ospedale Infantile Regina Margherita Turin, Italy

View Trial Details